Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gu Ben Hua Yu Fang refers to a category of Traditional Chinese Medicine (TCM) formulas designed to address various health conditions. These formulas typically aim to 'Gu Ben' (strengthen the root or fundamental aspects of the body) and 'Hua Yu' (transform blood stasis) or 'Hua Shi' (transform dampness) or 'Fang Xiao' (dispel wind), depending on the specific variant. For example, the Gu-Ben-Fang-Xiao decoction (GBFXD), derived from Yu-Ping-Feng-San, is used in respiratory diseases, particularly for asthma remission, where it modulates lipid metabolism by activating the AMP-activated protein kinase (AMPK) pathway. Another variant, the Gu-Ben-Hua-Shi (AESS) formula, has demonstrated clinical effects in treating atopic dermatitis by reducing skin lesions, regulating the Th1/Th2/Th17/Treg immune balance, and influencing Yes-associated protein (YAP) expression. These formulas are complex herbal preparations with multiple active components.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Gu Ben Hua Yu Fang.